Skip to main content

Revance will initially address one of the largest demands within the facial aesthetics category, glabellar (frown) lines.

Revance Clinical Program Update:

  • Product candidate DaxibotulinumtoxinA For Injection (RT002) has been evaluated in a Phase 2 head-to-head, active comparator study (BELMONT), completed last year in Canada, for the treatment of Glabellar Lines. Positive interim 6-month results were presented by Dr. Jean Carruthers, as a late-breaker at the 2015 AAD meeting.

For the latest information regarding our clinical development programs, please see our public filings with the Securities and Exchange Commissions, as well as the press releases we issue, or visit www.clinicaltrials.gov

Anti-Aging: Facts, Figures & Trends

  • Use of botulinum toxin products for aesthetic and therapeutic indications represents an estimated $3.4 billion market globally.
  • Botulinum toxin procedures continue to drive the nonsurgical aesthetic market and have remained the #1 nonsurgical procedure since 2000.
  • Botulinum toxin injections (aesthetic) have seen a 5,407% increase in number of procedures from 1997-2014.*
  • A recent quantitative study of 80 community dermatologists and cosmetic surgeons revealed that RT002 injectable, if approved, would address an unmet need by offering a longer duration of effect. This same group voiced a significant likelihood to use RT002 injectable and make it their treatment of choice.**

* 2015 ASAPS Statistical data

** Revance. Data on file.

Glabellar Lines

The glabella is the skin that sits between the eyebrows and above the nose.

Facial wrinkling is promoted by habitual facial expressions, aging, sun damage, smoking, poor hydration, and various other factors.

Aging theory suggests that wrinkles develop from incorrect repairs of injured elastic fibers and collagen fibers. Repeated extensions and compressions of the skin cause repeated injuries of extracellular fibers in derma. During the repairing process, some of the broken elastic fibers and collagen fibers are not regenerated and restored, but replaced by altered fibers.

Botulinum toxin treats glabellar (frown) lines by immobilizing the muscles that cause wrinkles.

Facts, Figures & Trends

  • Deeper muscles like those that form the glabellar (frown) lines may be better served by an injectable formulation like RT002.

Presentations & Publications

DaxibotuliunumtoxinA For Injection (RT002)

SAKURA Presentation:
BELMONT Publication:
BELMONT Presentations:

RT002 injectable and topical formulations are investigational product candidates. RT002 is currently undergoing clinical studies for both therapeutic and aesthetic indications.